Maternal Hemodynamics at 11-13 Weeks' Gestation in Gestational Diabetes Mellitus

被引:18
|
作者
Khalil, Asma [2 ]
Garcia-Mandujano, Rosario [2 ]
Chiriac, Roxana [2 ]
Akolekar, Ranjit
Nicolaides, Kypros H. [1 ,2 ]
机构
[1] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, Dept Fetal Med, London SE5 9RS, England
[2] Univ Coll London Hosp, Inst Womens Hlth, Dept Fetal Med, London, England
关键词
Pregnancy; Gestational diabetes; Arterial stiffness; Pulse wave velocity; Central systolic blood pressure; ARTERIAL STIFFNESS; CARDIOVASCULAR-DISEASE; SERUM HOMOCYSTEINE; PREECLAMPSIA; PRESSURE; WOMEN; RISK; PREDICTION; MORTALITY; AUGMENTATION;
D O I
10.1159/000336692
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Women who develop gestational diabetes mellitus (GDM) are at increased risk of type 2 diabetes and subsequent cardiovascular mortality and morbidity. Individuals with cardiovascular disorders have increased central aortic systolic blood pressure (SBPAo) and arterial stiffness. The hypothesis of this study is that increased 5BP(Ao) and arterial stiffness are apparent before the development of GDM. Methods: In this screening study, SBPAo, pulse wave velocity (PWV) and augmentation index (Alx) were measured in women with singleton pregnancies attending for routine antenatal care at 11-13 weeks' gestation. We compared SBPA, PWV and Alx, expressed as multiples of the median (MoM), after adjustment for maternal characteristics affecting these measurements, in women who subsequently developed GDM (n = 105) with the values in non-GDM controls (n = 6,736). Results: In the GDM group, compared to non-GDM controls, there was an increase in PWV (1.04 MoM, interquartile range (IQR) 0.93-1.15 vs. 1.00 MoM, IQR 0.90-1.12; p = 0.0131 and SBPAo (1.03 MoM, IQR 0.98-1.14 vs. 1.00 MoM, IQR 0.94-1.08; p < 0.0001) but no significant difference in the Alx (1.02 MoM, IQR 0.89-1.22 vs. 1.00 MoM, IQR 0.87-1.17; p = 0.118). Conclusion: Women who develop GDM have increased SBPAo and arterial stiffness from the first trimester of pregnancy before the clinical onset of GDM. copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:216 / 220
页数:5
相关论文
共 50 条
  • [41] The BS/BSOB Ratio in Aneuploidy Fetuses at 11-13 Weeks Gestation
    Hsiao, Ching Hua
    Cheng, Po Jen
    Shaw, S. W. Steven
    Tseng, Yin Jiun
    Chen, Ran Chou
    Chu, Woei-Chyn
    FETAL DIAGNOSIS AND THERAPY, 2015, 37 (04) : 321 - 326
  • [42] Blood pressure cutoffs at 11-13 weeks of gestation and risk of preeclampsia
    Slade, Laura J.
    Syngelaki, Argyro
    Wilson, Milly
    Mistry, Hiten D.
    Akolekar, Ranjit
    von Dadelszen, Peter
    Nicolaides, Kypros H.
    Magee, Laura A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2025, 232 (02)
  • [43] Body Mass Index at 11-13 Weeks' Gestation and Pregnancy Complications
    Syngelaki, Argyro
    Bredaki, Foteini E.
    Vaikousi, Eirini
    Maiz, Nerea
    Nicolaides, Kypros H.
    FETAL DIAGNOSIS AND THERAPY, 2011, 30 (04) : 250 - 265
  • [44] Serum podocalyxin for early detection of preeclampsia at 11-13 weeks of gestation
    Mansilla, Mary
    Wang, Yao
    Hyett, Jonathan
    Costa, Fabricio da Silva
    Nie, Guiying
    PLACENTA, 2018, 71 : 13 - 15
  • [45] Maternal Serum Vitamin D at 11-13 Weeks in Pregnancies Delivering Small for Gestational Age Neonates
    Ertl, Rebecca
    Yu, Christina K. H.
    Samaha, Robert
    Akolekar, Ranjit
    Nicolaides, Kypros H.
    FETAL DIAGNOSIS AND THERAPY, 2012, 31 (02) : 103 - 108
  • [46] P5.19: Maternal Hemodynamics at 11–13 Weeks of Gestation and the Risk of Pre-Eclampsia
    A. Khalil
    R. Akolekar
    A. Syngelaki
    M. ElKhaouly
    K. Nicolaides
    Artery Research, 2011, 5 (4) : 168 - 168
  • [47] Combined Screening for Preeclampsia and Small for Gestational Age at 11-13 Weeks
    Poon, Leona C. Y.
    Syngelaki, Argyro
    Akolekar, Ranjit
    Lai, Jonathan
    Nicolaides, Kypros H.
    FETAL DIAGNOSIS AND THERAPY, 2013, 33 (01) : 16 - 27
  • [48] Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsia
    Birdir, Cahit
    Janssen, Katharina
    Stanescu, Anca Daniela
    Enekwe, Antje
    Kasimir-Bauer, Sabine
    Gellhaus, Alexandra
    Kimmig, Rainer
    Koeninger, Angela
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (05) : 1033 - 1042
  • [49] Fetal Fraction in Maternal Plasma Cell-Free DNA at 11-13 Weeks' Gestation: Effect of Maternal and Fetal Factors
    Ashoor, Ghalia
    Poon, Leona
    Syngelaki, Argyro
    Mosimann, Beatrice
    Nicolaides, Kypros H.
    FETAL DIAGNOSIS AND THERAPY, 2012, 31 (04) : 237 - 243
  • [50] Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics
    Ashoor, G.
    Syngelaki, A.
    Poon, L. C. Y.
    Rezende, J. C.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 41 (01) : 26 - 32